Skip to main content

Table 4 Univariate analysis of variable associated with death for COVID-19 patients

From: Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China

VariableUnivariable
OR (95% CI)P value
Age1.102 (1.054–1.152)< 0.001*
Male6.114 (1.662–22.485)0.006*
Hypertension5.000 (1.748–14.301)0.003*
Diabetes4.881 (1.310–18.184)0.018*
Cardiovascular disease7.972 (2.290–27.753)0.001*
White blood cell count1.239 (1.055–1.455)0.009*
Neutrophil count1.257 (1.073–1.472)0.005*
Lymphocyte count0.234 (0.051–1.075)0.062
Platelet count0.987 (0.977–0.997)0.009*
Prothrombin time1.084 (0.737–1.595)0.683
Activated partial thromboplastin time0.998 (0.979–1.017)0.829
Creatine kinase1.001 (0.999–1.002)0.277
Creatine kinase-MB1.043 (1.008–1.079)0.015*
Lactate dehydrogenase1.006 (1.002–1.010)0.004*
Alanine aminotransferase1.020 (1.002–1.038)0.031*
Aspartate aminotransferase1.034 (1.015–1.054)< 0.001*
Total bilirubin1.070 (0.995–1.149)0.066
Blood urea nitrogen1.001 (0.985–1.016)0.943
Creatinine1.037 (1.015–1.058)0.001*
Tamiflu0.389 (0.047–3.209)0.380
  1. MB muscle and brain type
  2. *P < 0.05 was considered significant